These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19019047)

  • 1. Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain.
    Nicholson B
    Pain Pract; 2009; 9(1):71-81. PubMed ID: 19019047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.
    Barkin RL
    Am J Ther; 2008; 15(2):157-66. PubMed ID: 18356636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.
    Rauck RL
    Pain Pract; 2009; 9(6):468-79. PubMed ID: 19874536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain.
    Pascual ML; Fleming RR; Gana TJ; Vorsanger GJ
    Curr Med Res Opin; 2007 Oct; 23(10):2531-42. PubMed ID: 17825129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic management of sleep disturbances in noncancer-related pain.
    Miaskowski C
    Pain Manag Nurs; 2009 Mar; 10(1):3-13. PubMed ID: 19264278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management.
    Fine PG; Mahajan G; McPherson ML
    Pain Med; 2009 Jul; 10 Suppl 2():S79-88. PubMed ID: 19691687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tramadol ER in the treatment of chronic pain.
    Rosenberg MT
    Int J Clin Pract; 2009 Oct; 63(10):1531-43. PubMed ID: 19769710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tramadol extended-release formulations in the management of pain due to osteoarthritis.
    Mongin G
    Expert Rev Neurother; 2007 Dec; 7(12):1775-84. PubMed ID: 18052769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic pain management issues in the primary care setting and the utility of long-acting opioids.
    Zorba Paster R
    Expert Opin Pharmacother; 2010 Aug; 11(11):1823-33. PubMed ID: 20629606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic.
    Gibofsky A; Barkin RL
    Am J Ther; 2008; 15(3):241-55. PubMed ID: 18496262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KADIAN (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain.
    Ross EL; Hahn K
    Int J Clin Pract; 2008 Mar; 62(3):471-9. PubMed ID: 18261077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid formulations: tailoring to the needs in chronic pain.
    Reder RF
    Eur J Pain; 2001; 5 Suppl A():109-11. PubMed ID: 11798229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain.
    Nicholson B
    Postgrad Med; 2013 Jan; 125(1):115-27. PubMed ID: 23391677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release formulations of tramadol in the treatment of chronic pain.
    Pergolizzi JV; Taylor R; Raffa RB
    Expert Opin Pharmacother; 2011 Aug; 12(11):1757-68. PubMed ID: 21609187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches to analgesic drug delivery for chronic pain.
    Carr DB; Sendil D
    Technol Health Care; 2002; 10(3-4):227-35. PubMed ID: 12118145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain.
    Rauck R; Ma T; Kerwin R; Ahdieh H
    Pain Med; 2008 Oct; 9(7):777-85. PubMed ID: 18950436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to optimize pain management with opioids while minimizing risk of abuse.
    Brennan MJ; Stanos S
    PM R; 2010 Jun; 2(6):544-58. PubMed ID: 20630441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.